Literature DB >> 26652053

Understanding differences between synthetic and natural antibodies can help improve antibody engineering.

Anat Burkovitz1, Yanay Ofran1.   

Abstract

Synthetic libraries are a major source of human-like antibody (Ab) drug leads. To assess the similarity between natural Abs and the products of these libraries, we compared large sets of natural and synthetic Abs using "CDRs Analyzer," a tool we introduce for structural analysis of Ab-antigen (Ag) interactions. Natural Abs, we found, recognize their Ags by combining multiple complementarity-determining regions (CDRs) to create an integrated interface. Synthetic Abs, however, rely dominantly, sometimes even exclusively on CDRH3. The increased contribution of CDRH3 to Ag binding in synthetic Abs comes with a substantial decrease in the involvement of CDRH2 and CDRH1. Furthermore, in natural Abs CDRs specialize in specific types of non-covalent interactions with the Ag. CDRH1 accounts for a significant portion of the cation-pi interactions; CDRH2 is the major source of salt-bridges and CDRH3 accounts for most hydrogen bonds. In synthetic Abs this specialization is lost, and CDRH3 becomes the main sources of all types of contacts. The reliance of synthetic Abs on CDRH3 reduces the complexity of their interaction with the Ag: More Ag residues contact only one CDR and fewer contact 3 CDRs or more. We suggest that the focus of engineering attempts on CDRH3 results in libraries enriched with variants that are not natural-like. This may affect not only Ag binding, but also Ab expression, stability and selectivity. Our findings can help guide library design, creating libraries that can bind more epitopes and Abs that better mimic the natural antigenic interactions.

Entities:  

Keywords:  Antigen binding site; antibody–antigen interactions; human-like antibodies; libraries; synthetic

Mesh:

Substances:

Year:  2015        PMID: 26652053      PMCID: PMC4966605          DOI: 10.1080/19420862.2015.1123365

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  65 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Antibody humanization: a case of the 'Emperor's new clothes'?

Authors:  M Clark
Journal:  Immunol Today       Date:  2000-08

3.  AB-Bind: Antibody binding mutational database for computational affinity predictions.

Authors:  Sarah Sirin; James R Apgar; Eric M Bennett; Amy E Keating
Journal:  Protein Sci       Date:  2015-11-06       Impact factor: 6.725

4.  Analyzing the "degree of humanness" of antibody sequences.

Authors:  K R Abhinandan; Andrew C R Martin
Journal:  J Mol Biol       Date:  2007-03-14       Impact factor: 5.469

5.  Conformations of the third hypervariable region in the VH domain of immunoglobulins.

Authors:  V Morea; A Tramontano; M Rustici; C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1998-01-16       Impact factor: 5.469

Review 6.  Antibody specific epitope prediction-emergence of a new paradigm.

Authors:  Inbal Sela-Culang; Yanay Ofran; Bjoern Peters
Journal:  Curr Opin Virol       Date:  2015-03-31       Impact factor: 7.090

7.  A systematic comparison of free and bound antibodies reveals binding-related conformational changes.

Authors:  Inbal Sela-Culang; Shahar Alon; Yanay Ofran
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

8.  Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis.

Authors:  Geertje M Bartelds; Carla A Wijbrandts; Michael T Nurmohamed; Steven Stapel; Willem F Lems; Lucien Aarden; Ben A C Dijkmans; Paul Peter Tak; Gerrit Jan Wolbink
Journal:  Ann Rheum Dis       Date:  2007-02-14       Impact factor: 19.103

9.  Large-scale analysis of somatic hypermutations in antibodies reveals which structural regions, positions and amino acids are modified to improve affinity.

Authors:  Anat Burkovitz; Inbal Sela-Culang; Yanay Ofran
Journal:  FEBS J       Date:  2013-11-26       Impact factor: 5.542

10.  Structural consensus among antibodies defines the antigen binding site.

Authors:  Vered Kunik; Bjoern Peters; Yanay Ofran
Journal:  PLoS Comput Biol       Date:  2012-02-23       Impact factor: 4.475

View more
  6 in total

1.  Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.

Authors:  Jinhui Dong; Robert W Cross; Michael P Doyle; Nurgun Kose; Jarrod J Mousa; Edward J Annand; Viktoriya Borisevich; Krystle N Agans; Rachel Sutton; Rachel Nargi; Mahsa Majedi; Karla A Fenton; Walter Reichard; Robin G Bombardi; Thomas W Geisbert; James E Crowe
Journal:  Cell       Date:  2020-12-10       Impact factor: 41.582

Review 2.  Potential of Phage Display Antibody Technology for Cardiovascular Disease Immunotherapy.

Authors:  Soo Ghee Yeoh; Jia Siang Sum; Jing Yi Lai; W Y Haniff W Isa; Theam Soon Lim
Journal:  J Cardiovasc Transl Res       Date:  2021-08-31       Impact factor: 3.216

Review 3.  Antibodies to combat viral infections: development strategies and progress.

Authors:  Giuseppe Pantaleo; Bruno Correia; Craig Fenwick; Victor S Joo; Laurent Perez
Journal:  Nat Rev Drug Discov       Date:  2022-06-20       Impact factor: 112.288

4.  Alanine Mutagenesis in the Complementarity Determining Region 3 of the MTB and HIV-1 Peptide-Bispecific T Cell Receptor Beta Chain Affects Ligand Recognition.

Authors:  Chao-Ying Zhou; Rui-Ning Wang; Qian Wen; Wen-Ting He; Shi-Meng Zhang; Xia-Lin Du; Jia-Hui Yang; Li Ma
Journal:  Front Immunol       Date:  2017-08-16       Impact factor: 7.561

5.  Restricted epitope specificity determined by variable region germline segment pairing in rodent antibody repertoires.

Authors:  Yi-Chun Hsiao; Ying-Jiun J Chen; Leonard D Goldstein; Jia Wu; Zhonghua Lin; Kellen Schneider; Subhra Chaudhuri; Aju Antony; Kanika Bajaj Pahuja; Zora Modrusan; Dhaya Seshasayee; Somasekar Seshagiri; Isidro Hötzel
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

6.  Peptide barcoding for one-pot evaluation of sequence-function relationships of nanobodies.

Authors:  Yusei Matsuzaki; Wataru Aoki; Takumi Miyazaki; Shunsuke Aburaya; Yuta Ohtani; Kaho Kajiwara; Naoki Koike; Hiroyoshi Minakuchi; Natsuko Miura; Tetsuya Kadonosono; Mitsuyoshi Ueda
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.